相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults
Erik Stomrud et al.
ARCHIVES OF NEUROLOGY (2010)
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Geert De Meyer et al.
ARCHIVES OF NEUROLOGY (2010)
Apolipoprotein E4allele in the normal elderly: neuropsychologic and brain MRI correlates
H. Schmidt et al.
CLINICAL GENETICS (2010)
Genetic connections between neurological disorders and cholesterol metabolism
Ingemar Bjorkhem et al.
JOURNAL OF LIPID RESEARCH (2010)
CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
Anders M. Fjell et al.
JOURNAL OF NEUROSCIENCE (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
The clinical use of structural MRI in Alzheimer disease
Giovanni B. Frisoni et al.
NATURE REVIEWS NEUROLOGY (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study
Duygu Tosun et al.
NEUROBIOLOGY OF AGING (2010)
Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort
Shannon L. Risacher et al.
NEUROBIOLOGY OF AGING (2010)
Serial MRI and CSF biomarkers in normal aging, MCI, and AD
P. Vemuri et al.
NEUROLOGY (2010)
Apolipoprotein E-Dependent Accumulation of Alzheimer Disease-Related Lesions Begins in Middle Age
Eloise Kok et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
Barbara J. Snider et al.
ARCHIVES OF NEUROLOGY (2009)
MRI of hippocampal volume loss in early Alzheimers disease in relation to ApoE genotype and biomarkers
N. Schuff et al.
BRAIN (2009)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease
Clifford R. Jack et al.
BRAIN (2009)
Rapid Progression from Mild Cognitive Impairment to Alzheimer's Disease in Subjects with Elevated Levels of Tau in Cerebrospinal Fluid and the APOE ε4/ε4 Genotype
Elin S. Blom et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The role of tau in neurodegeneration
Tania F. Gendron et al.
MOLECULAR NEURODEGENERATION (2009)
Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy
Guojun Bu
NATURE REVIEWS NEUROSCIENCE (2009)
The effects of normal aging and ApoE genotype on the levels of CSF biomarkers for Alzheimer's disease
Lidia Glodzik-Sobanska et al.
NEUROBIOLOGY OF AGING (2009)
Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment
Miroslaw Brys et al.
NEUROBIOLOGY OF AGING (2009)
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
A. Drzezga et al.
NEUROLOGY (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjects Diagnostic discrimination and cognitive correlations
P. Vemuri et al.
NEUROLOGY (2009)
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
M. I. Kester et al.
NEUROLOGY (2009)
The Role of Apolipoprotein E in Alzheimer's Disease
Jungsu Kim et al.
NEURON (2009)
Longitudinal Study of CSF Biomarkers in Patients with Alzheimer's Disease
Peder Buchhave et al.
PLOS ONE (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Ventricular enlargement as a possible measure of Alzheimers disease progression validated using the Alzheimers disease neuroimaging initiative database
Sean M. Nestor et al.
BRAIN (2008)
Increasing CSF phospho-tau levels during cognitive decline and progression to dementia
Christin Andersson et al.
NEUROBIOLOGY OF AGING (2008)
Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature
Breno S. O. Diniz et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
Atrophy rates accelerate in amnestic mild cognitive impairment
C. R. Jack et al.
NEUROLOGY (2008)
Apolipoprotein E and cholesterol in aging and disease in the brain
Elena Posse de Chaves et al.
FUTURE LIPIDOLOGY (2008)
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment
L. A. van de Pol et al.
NEUROLOGY (2007)
CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment -: A follow-up study
G. Li et al.
NEUROLOGY (2007)
Longitudinal stability of CSF biomarkers in Alzheimer's disease
Kaj Blennow et al.
NEUROSCIENCE LETTERS (2007)
The C-terminal lipid-binding domain of apolipoprotein E is a highly efficient mediator of ABCA1-dependent cholesterol efflux that promotes the assembly of high-density lipoproteins
Charulatha Vedhachalam et al.
BIOCHEMISTRY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
CSF A beta 42, Tau and phosphorylated Tau, APOE epsilon 4 allele and MCI type in progressive MCI
Sanna-Kaisa Herukka et al.
NEUROBIOLOGY OF AGING (2007)
CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease
Katharina Buerger et al.
BRAIN (2006)
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid β-amyloid 42 in adults with normal cognition
Elaine R. Peskind et al.
ARCHIVES OF NEUROLOGY (2006)
Implication of apoE isoforms in cholesterol metabolism by primary rat hippocampal neurons and astrocytes
Alfred Rapp et al.
BIOCHIMIE (2006)
Age effects on atrophy rates of entorhinal cortex and hippocampus
AT Du et al.
NEUROBIOLOGY OF AGING (2006)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
MJ de Leon et al.
NEUROBIOLOGY OF AGING (2006)
Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence
M. Kivipelto et al.
ACTA NEUROLOGICA SCANDINAVICA (2006)
Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells:: ApoE structure as a potential therapeutic target
SM Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism
EM Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials
M Grundman et al.
ARCHIVES OF NEUROLOGY (2004)
Cerebrospinal fluid β-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease:: The effect of APOE ε4 allele
T Sunderland et al.
BIOLOGICAL PSYCHIATRY (2004)
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study
H Hampel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice
FM Harris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Outsourcing in the brain: do neurons depend on cholesterol delivery by astrocytes?
FW Pfrieger
BIOESSAYS (2003)
Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice
JS Gong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice
I Tesseur et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
